| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP Finance/ Prin Fin&Acct Offic | Controller/ Prin Fin&Acct Offic
1 company
Austin Mark John is a VP Finance/ Prin Fin&Acct Offic at Perspective Therapeutics, Inc.. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $252K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2022 | CATX Perspective Therapeutics, Inc. | VP Finance/ Prin Fin&Acct Offic | Buy | 18,800 | $0.29 | $5,384.22 | +24.9% | +21.1% | +81.2% | |
| Oct 22, 2020 | CATX Perspective Therapeutics, Inc. | Controller/ Prin Fin&Acct Offic | Buy | 19,230 | $0.52 | $9,999.60 | +120.2% | - | - | |
| Nov 16, 2018 | CATX Perspective Therapeutics, Inc. | Controller/ Prin Fin&Acct Offic | Buy | 4,283 | $0.40 | $1,702.92 | +36.6% | - | - | |
| Nov 13, 2018 | CATX Perspective Therapeutics, Inc. | Controller/ Prin Fin&Acct Offic | Buy | 2,452 | $0.41 | $1,005.32 | +26.5% | - | - | |
| Nov 24, 2017 | CATX Perspective Therapeutics, Inc. | Controller/ Prin Fin&Acct Offic | Buy | 9,265 | $0.48 | $4,489.93 | +30.3% | - | - |